PL2834248T3 - Nowe pochodne tienopirymidynowe, sposoby ich otrzymywania i ich zastosowania terapeutyczne - Google Patents
Nowe pochodne tienopirymidynowe, sposoby ich otrzymywania i ich zastosowania terapeutyczneInfo
- Publication number
- PL2834248T3 PL2834248T3 PL13716241.8T PL13716241T PL2834248T3 PL 2834248 T3 PL2834248 T3 PL 2834248T3 PL 13716241 T PL13716241 T PL 13716241T PL 2834248 T3 PL2834248 T3 PL 2834248T3
- Authority
- PL
- Poland
- Prior art keywords
- processes
- preparation
- therapeutic uses
- thienopyrimidine derivatives
- novel thienopyrimidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Professional, Industrial, Or Sporting Protective Garments (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1253044A FR2988722B1 (fr) | 2012-04-03 | 2012-04-03 | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2834248T3 true PL2834248T3 (pl) | 2016-09-30 |
Family
ID=48095815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL13716241.8T PL2834248T3 (pl) | 2012-04-03 | 2013-04-02 | Nowe pochodne tienopirymidynowe, sposoby ich otrzymywania i ich zastosowania terapeutyczne |
Country Status (38)
Country | Link |
---|---|
US (6) | US9115140B2 (pl) |
EP (1) | EP2834248B1 (pl) |
JP (1) | JP6096278B2 (pl) |
KR (1) | KR102039764B1 (pl) |
CN (2) | CN104540834B (pl) |
AR (1) | AR090572A1 (pl) |
AU (1) | AU2013244992B2 (pl) |
BR (1) | BR112014024489B1 (pl) |
CA (1) | CA2868685C (pl) |
CL (1) | CL2014002661A1 (pl) |
CO (1) | CO7091179A2 (pl) |
CR (1) | CR20140435A (pl) |
CY (1) | CY1117843T1 (pl) |
DK (1) | DK2834248T3 (pl) |
DO (1) | DOP2014000216A (pl) |
EA (1) | EA025558B1 (pl) |
ES (1) | ES2577382T3 (pl) |
FR (1) | FR2988722B1 (pl) |
HK (2) | HK1201263A1 (pl) |
HR (1) | HRP20160649T1 (pl) |
HU (1) | HUE027895T2 (pl) |
IL (1) | IL234960A (pl) |
MA (1) | MA37384B1 (pl) |
MX (1) | MX355104B (pl) |
MY (1) | MY166151A (pl) |
PE (1) | PE20150289A1 (pl) |
PH (1) | PH12014502180B1 (pl) |
PL (1) | PL2834248T3 (pl) |
PT (1) | PT2834248E (pl) |
RS (1) | RS54850B1 (pl) |
SG (1) | SG11201406091RA (pl) |
SI (1) | SI2834248T1 (pl) |
TN (1) | TN2014000415A1 (pl) |
TW (1) | TWI579288B (pl) |
UA (1) | UA112685C2 (pl) |
UY (1) | UY34725A (pl) |
WO (1) | WO2013150036A1 (pl) |
ZA (1) | ZA201407021B (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
CA2950330C (en) * | 2014-05-28 | 2019-04-30 | Shanghai Fochon Pharmaceutical Co Ltd | Certain protein kinase inhibitors |
US10259816B2 (en) | 2015-04-24 | 2019-04-16 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof |
CN108779117B (zh) * | 2015-12-27 | 2021-08-31 | 重庆复创医药研究有限公司 | 一类激酶抑制剂 |
MX2018013573A (es) | 2016-05-07 | 2019-08-01 | Shanghai Fochon Pharmaceutical Co Ltd | Ciertos inhibidores de la proteína cinasa. |
MX2020002944A (es) | 2017-09-14 | 2020-09-28 | Daiichi Sankyo Co Ltd | Compuesto que tiene estructura ciclica. |
EP3762368B1 (en) | 2018-03-08 | 2022-01-26 | Incyte Corporation | Aminopyrazine diol compounds as pi3k-y inhibitors |
CN110551142B (zh) * | 2018-05-31 | 2023-05-12 | 上海再极医药科技有限公司 | 一种稠环嘧啶类化合物的盐、晶型及其制备方法和应用 |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN110922421B (zh) * | 2019-12-17 | 2023-05-05 | 安徽英特美科技有限公司 | 一种n-甲基-1,2,5,6-四氢吡啶-4-硼酸频哪醇酯的合成方法 |
US20230192653A1 (en) * | 2020-03-13 | 2023-06-22 | Guangzhou Maxinovel Pharmaceuticals Co., Ltd. | Novel Therapeutic Methods |
CN116731035A (zh) * | 2022-03-08 | 2023-09-12 | 广州再极医药科技有限公司 | 一种噻吩并嘧啶类化合物、中间体、其制备方法、组合物和应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1470356A1 (de) * | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
PL340589A1 (en) * | 1997-11-11 | 2001-02-12 | Pfizer Prod Inc | Derivatives of thienepyrimidine and thienepyridine useful as anticarcinogenic agents |
WO2000075145A1 (en) | 1999-06-03 | 2000-12-14 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
DE10042997A1 (de) | 2000-09-01 | 2002-03-14 | Merck Patent Gmbh | Thienopyrimidine |
WO2007084815A2 (en) | 2006-01-19 | 2007-07-26 | Janssen Pharmaceutica, N.V. | Substituted thienopyrimidine kinase inhibitors |
CL2007001166A1 (es) * | 2006-04-26 | 2008-01-25 | Piramed Ltd | Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica |
PL2091918T3 (pl) | 2006-12-08 | 2015-02-27 | Novartis Ag | Związki i kompozycje jako inhibitory kinazy białkowej |
US8354408B2 (en) * | 2007-11-15 | 2013-01-15 | Ym Biosciences Australia Pty Ltd | N-containing heterocyclic compounds |
DE102008017853A1 (de) | 2008-04-09 | 2009-10-15 | Merck Patent Gmbh | Thienopyrimidine |
KR101147550B1 (ko) * | 2009-10-22 | 2012-05-17 | 한국과학기술연구원 | 단백질 키나아제 저해활성을 가지는 2,7-치환된 티에노[3,2-d]피리미딘 화합물 |
KR101094446B1 (ko) * | 2009-11-19 | 2011-12-15 | 한국과학기술연구원 | 단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물 |
WO2012004900A1 (en) | 2010-07-09 | 2012-01-12 | Aska Pharmaceutical Co., Ltd. | Thienopyrimidine compounds |
FR2988722B1 (fr) | 2012-04-03 | 2014-05-09 | Sanofi Sa | Nouveaux derives de thienopyrimidines, leurs procedes de preparation et leurs utilisations therapeutiques |
-
2012
- 2012-04-03 FR FR1253044A patent/FR2988722B1/fr active Active
-
2013
- 2013-02-04 UA UAA201411826A patent/UA112685C2/uk unknown
- 2013-04-02 RS RS20160436A patent/RS54850B1/sr unknown
- 2013-04-02 PE PE2014001523A patent/PE20150289A1/es active IP Right Grant
- 2013-04-02 KR KR1020147030322A patent/KR102039764B1/ko active IP Right Grant
- 2013-04-02 SI SI201330203A patent/SI2834248T1/sl unknown
- 2013-04-02 WO PCT/EP2013/056958 patent/WO2013150036A1/en active Application Filing
- 2013-04-02 CA CA2868685A patent/CA2868685C/en active Active
- 2013-04-02 MX MX2014011921A patent/MX355104B/es active IP Right Grant
- 2013-04-02 HU HUE13716241A patent/HUE027895T2/en unknown
- 2013-04-02 EA EA201491820A patent/EA025558B1/ru not_active IP Right Cessation
- 2013-04-02 BR BR112014024489-8A patent/BR112014024489B1/pt not_active IP Right Cessation
- 2013-04-02 MA MA37384A patent/MA37384B1/fr unknown
- 2013-04-02 CN CN201380029174.4A patent/CN104540834B/zh active Active
- 2013-04-02 EP EP13716241.8A patent/EP2834248B1/en active Active
- 2013-04-02 PT PT137162418T patent/PT2834248E/pt unknown
- 2013-04-02 PL PL13716241.8T patent/PL2834248T3/pl unknown
- 2013-04-02 US US13/855,246 patent/US9115140B2/en active Active
- 2013-04-02 ES ES13716241.8T patent/ES2577382T3/es active Active
- 2013-04-02 JP JP2015503860A patent/JP6096278B2/ja active Active
- 2013-04-02 AU AU2013244992A patent/AU2013244992B2/en active Active
- 2013-04-02 MY MYPI2014002724A patent/MY166151A/en unknown
- 2013-04-02 CN CN201710950612.0A patent/CN107652303B/zh active Active
- 2013-04-02 SG SG11201406091RA patent/SG11201406091RA/en unknown
- 2013-04-02 DK DK13716241.8T patent/DK2834248T3/en active
- 2013-04-03 AR ARP130101067A patent/AR090572A1/es active IP Right Grant
- 2013-04-03 TW TW102112260A patent/TWI579288B/zh active
- 2013-04-03 UY UY0001034725A patent/UY34725A/es not_active Application Discontinuation
-
2014
- 2014-09-22 CR CR20140435A patent/CR20140435A/es unknown
- 2014-09-25 DO DO2014000216A patent/DOP2014000216A/es unknown
- 2014-09-26 ZA ZA2014/07021A patent/ZA201407021B/en unknown
- 2014-09-29 PH PH12014502180A patent/PH12014502180B1/en unknown
- 2014-09-30 TN TNP2014000415A patent/TN2014000415A1/fr unknown
- 2014-10-02 CL CL2014002661A patent/CL2014002661A1/es unknown
- 2014-10-02 IL IL234960A patent/IL234960A/en active IP Right Grant
- 2014-10-03 CO CO14219119A patent/CO7091179A2/es unknown
-
2015
- 2015-02-17 HK HK15101753.8A patent/HK1201263A1/zh unknown
- 2015-07-08 US US14/794,574 patent/US9744176B2/en active Active
-
2016
- 2016-06-10 HR HRP20160649TT patent/HRP20160649T1/hr unknown
- 2016-06-15 CY CY20161100522T patent/CY1117843T1/el unknown
-
2017
- 2017-07-26 US US15/660,694 patent/US10220044B2/en active Active
-
2018
- 2018-06-08 HK HK18107478.6A patent/HK1248214A1/zh unknown
-
2019
- 2019-01-10 US US16/245,131 patent/US10500212B2/en active Active
- 2019-10-30 US US16/668,555 patent/US10736904B2/en active Active
-
2020
- 2020-06-29 US US16/915,782 patent/US10980816B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1248214A1 (zh) | 新噻吩並嘧啶衍生物、其製備方法及其治療用途 | |
IL231386A0 (en) | Pyrazoloquinolinone derivatives, their preparation and medical use | |
ZA201404625B (en) | Polycyclic derivatives, preparation method and medical uses thereof | |
EP2763998A4 (en) | TRI-HETEROCYCLIC DERIVATIVES, MANUFACTURING METHOD AND USES THEREOF | |
EP2937326A4 (en) | PROCESS FOR THE PREPARATION OF 1, 3, 3, 3-TETRAFLUOROPROPENE | |
GB2502390B (en) | Novel Ni complex and its derivatives, producing method, and the use thereof as antioxidant | |
IL252033B (en) | History of spiro and processes for their preparation | |
EP2813495A4 (en) | 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF | |
EP2903979A4 (en) | Novel compounds, their preparation and use | |
HK1211570A1 (en) | Indene derivatives, their preparation and use as medicaments | |
EP2874994A4 (en) | 3,5, N-trihydroxyalkanoamide and derivatives: A process for the preparation thereof and use thereof | |
HK1212968A1 (zh) | 氨基環丁烷衍生物、其製備方法及其用作藥物的用途 | |
HK1209127A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
HK1204613A1 (en) | Substituted pyrano and furanoquinolines, their preparation and use as medicaments | |
EP2817004A4 (en) | BOUVARDIN DERIVATIVES AND THEIR THERAPEUTIC USES | |
EP2804853A4 (en) | THERAPEUTIC USES | |
PL398021A1 (pl) | Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania | |
PL398018A1 (pl) | Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania | |
PL398496A1 (pl) | Iminowa pochodna (-)-fenchonu i sposób jej wytwarzania | |
PL398984A1 (pl) | Sposób wytwarzania (Z)-6,4'-dihydroksy-4-metoksy-7- prenyloauronu | |
PL399603A1 (pl) | Sposób wytwarzania 3β,15α-dihydroksy-5α-androst-17-onu | |
PL398987A1 (pl) | (Z)-6-siarczan-6,4'-dihydroksy-7-prenylo-4-metoksyauronu i sposób jego wytwarzania | |
PL398989A1 (pl) | (Z)-6-O-ß-D-4'''-O-metylo-glukopiranozylo-4'-hydroksy-4-metoksy-7-prenyloauron i sposób jego wytwarzania | |
AU2012904991A0 (en) | Therapeutic Compounds and Uses Thereof | |
PL395175A1 (pl) | Nowe pochodne dekstrometorfanu i sposób ich wytwarzania |